Is Arthrodesis a Reliable Salvage Option following Two-Stage Revision for Suspected Infection in Proximal Tibial Replacements? A Multi-Institutional Study.


Journal

The journal of knee surgery
ISSN: 1938-2480
Titre abrégé: J Knee Surg
Pays: Germany
ID NLM: 101137599

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 19 9 2018
medline: 19 12 2019
entrez: 19 9 2018
Statut: ppublish

Résumé

The aim of this multicentric retrospective study was to verify whether knee arthrodesis (KA) is a viable reconstructive option after two-stage revision for infection of proximal tibia (PT) endoprosthetic reconstruction (EPR). Sixty patients who underwent a two-stage revision were included. Definitive EPR or a KA with a modular system was performed following consideration of soft tissue and extensor mechanism conditions. Patients were evaluated with Musculoskeletal Tumor Society Score and Oxford Knee Score. Implant survival was assessed on the basis of recurrence of infection. Five patients did not receive any reconstruction after the first stage. In 14 cases, a KA was performed, and in 41, an EPR was implanted. At 5 years follow-up, reinfection rate in the KA group was lower (10 vs. 17.5% in KA and EPR groups, respectively). In reinfected patients, the KA group had a reduced rate of amputation when compared with those with EPR (50 vs. 88%). Functional evaluation did not show any significant differences between the two groups. A successful KA using a modular implant can eradicate infection and allow preservation of the limb with good function and good pain relief in after two-stage revision for an infected PT EPR.

Identifiants

pubmed: 30227450
doi: 10.1055/s-0038-1672121
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

911-918

Informations de copyright

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Déclaration de conflit d'intérêts

None.

Auteurs

Andrea Sambri (A)

Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy.

Giuseppe Bianchi (G)

Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy.

Michael Parry (M)

Department of Orthopedic Oncology, Royal Orthopaedic Hospital, Birmingham, United Kingdom.

Filippo Frenos (F)

Department of Orthopedic Oncology, Azienda Ospedaliero Universitaria Careggi, Firenze, Toscana, Italy.

Domenico Campanacci (D)

Department of Orthopedic Oncology, Azienda Ospedaliero Universitaria Careggi, Firenze, Toscana, Italy.

Davide Donati (D)

Department of Orthopedic Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy.

Lee Jeys (L)

Department of Orthopedic Oncology, Royal Orthopaedic Hospital, Birmingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH